4.3 Review

Cardiovascular pharmacology and physiology of the isoprostanes

Journal

FUNDAMENTAL & CLINICAL PHARMACOLOGY
Volume 20, Issue 5, Pages 417-427

Publisher

WILEY
DOI: 10.1111/j.1472-8206.2006.00435.x

Keywords

atherosclerosis; hypertension; ischemia; isoprostane; lipid peroxidation; vasoconstriction

Ask authors/readers for more resources

F-2-isoprostanes are a complex family of compounds produced from arachidonic acid via a free radical-catalyzed mechanism. Their quantification as a pathophysiological biomarker provides a unique opportunity to investigate lipid peroxidation in vascular diseases. Their measurement also provides an interesting biomarker for the rational dose selection of antioxidants in vascular diseases where oxidative stress might be involved. In addition to their use as biomarkers, some isoprostanes possess a biological activity. The 15-series F-2- and E-2-isoprostanes mediate vasoconstriction in different vascular beds and species. In addition, 15-F-2t-IsoP induces smooth muscle cells mitogenesis and monocyte adhesion to endothelial cells. The data available supports but does not prove the hypothesis that isoprostanes are involved in vascular physiology and pathogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available